Conventional Tools for Predicting Satisfactory Response to Neoadjuvant Chemotherapy in HR+/HER2- Breast Cancer Patients.
Oprea AL, Gulluoglu B, Aytin YE, Eren OC, Aral C, Szekely TB, Tastekin E, Kaya H, Bademler S, Karanlik H, Sezer A, Ugurlu MU, Turdean SG, Georgescu R, Marginean C.
Oprea AL, et al. Among authors: turdean sg.
Breast Care (Basel). 2023 Oct;18(5):344-353. doi: 10.1159/000531117. Epub 2023 May 20.
Breast Care (Basel). 2023.
PMID: 37901046